AQST’s FDA Roadblock Is Packaging, Not Product—Anaphylm’s Path Forward Looks Manageable
Market Chameleon (Mon, 2-Feb 10:29 AM)
FDA Raises Packaging Concerns for Aquestive’s Anaphylm, but Company Eyes Rapid Resolution and Global Expansion
Market Chameleon (Mon, 2-Feb 8:39 AM)
FDA Review for Anaphylm Remains Ongoing: Aquestive Pursues Global Regulatory Approvals Amid Unresolved Application Issues
Market Chameleon (Fri, 9-Jan 7:51 AM)
